Objective, peer-reviewed reporting on therapeutic peptides, regulatory updates, clinical trial results, and scientific consensus. No hype. No product sales.
Articles tagged Peptide Safety.
Injectable peptide stacks are surging on social media. Alex Keane explains how to separate GLP-1 evidence from the BPC-157, TB-500, and wellness-peptide evidence gap.
Retatrutide is surging in search and social conversation. Alex Keane explains the triple-agonist science, clinical data, and online peptide safety risks behind today’s trend.
Retatrutide is driving a new wave of peptide searches after Phase 3 weight-loss data. Alex Keane explains the triple-agonist science, safety signals, and why online peptide products deserve caution.
Retatrutide and BPC-157 are driving today’s peptide safety debate. Alex Keane explains why GLP-1 science, recovery peptides, and evidence gaps are colliding in 2026.
No articles match that search.